Scancell Holdings plc

Direct answer

Scancell Holdings plc is publicly traded on LSE under the ticker SCLP.L.

Scancell Holdings plc is a clinical-stage biopharmaceutical firm focused on discovering and developing innovative vaccine and antibody treatments. Its mission is to address significant unmet medical needs in both cancer and infectious diseases. The company's pipeline features several promising candidates, including SCIB1, currently in Phase II clinical trials for metastatic melanoma; SCIB2, aimed at non-small cell...

Can you invest in Scancell Holdings plc?

Yes. Scancell Holdings plc is publicly traded on LSE under the ticker SCLP.L.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Scancell Holdings plc

Detailed equity research is provided by MarketSnap.